Item 8.01 Other Events.

On October 25, 2022, the Company issued a press release with respect the CEO's Letter to Stockholders. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits



Exhibit
Number    Description
99.1        Press Release Bone Biologics CEO Issues Letter to Stockholders, dated
          October 25, 2022

104       Cover Page Interactive Data File (embedded within the Inline XBRL
          document)

© Edgar Online, source Glimpses